This inhibitory effect not only affects CD4+ and CD8+ T cells but also promotes the expansion of Tregs in the TME, which have a stronger immunosuppressive function and can further limit anti-tumor immune responses through cell contact (35, 44). This evidence concerns the gene CD8A and neoplasm.